Speaker illustration

Doctor Ahmed Elsanhoury

Charite University Hospital, Berlin (Germany)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Elsanhoury is working as post-doctoral clinical scientist at the Berlin Institute of Health- Center for Regenerative Therapies- Charite´-University of Medicine -Berlin. His career is focused on evaluating and developing new therapeutic strategies against cardiomyopathies, where he is engaged in several clinical studies. His areas of expertise include clinical pharmacology, cardiology and clinical trials. In 2020, Dr. Elsanhoury has obtained a joint doctoral degree from Humboldt University of Berlin and Charite´ with great destinction. He speaks fluent English, German and Arabic.

THE NATURAL COURSE OF MYOCARDITIS IN PATIENTS WITH MYOCARDIAL PARVOVIRUS B19 AND HUMAN HERPESVIRUS 6 DNA CO-PRESENCE

Event: WG-M&PD Annual Meeting 2022

Topic: Myocardial Disease

Session: Young Investigator Awards - Myocardial / Pericardial Diseases

Thumbnail

Role of immunosuppression in patients with lymphocytic myocarditis and myocardial parvovirus B19 with or without human herpesvirus 6 co-presence

Event: ESC Congress 2022

Topic: Myocarditis

Session: Myocarditis: still many open questions

Thumbnail

ESC 365 is supported by

logo Novo Nordisk